Kelyniam Global, Inc. Share Price Other OTC
Equities
KLYG
US4883591004
Advanced Medical Equipment & Technology
Sales 2022 | 3.02M 238M | Sales 2023 | 2.67M 211M | Capitalization | 1.83M 144M |
---|---|---|---|---|---|
Net income 2022 | - 0 | Net income 2023 | - 0 | EV / Sales 2022 | 0.99 x |
Net Debt 2022 | 560K 44.14M | Net Debt 2023 | 623K 49.11M | EV / Sales 2023 | 0.92 x |
P/E ratio 2022 |
-24.8
x | P/E ratio 2023 |
-8.35
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 53.55% |
Managers | Title | Age | Since |
---|---|---|---|
Ross Bjella
CEO | Chief Executive Officer | - | 08/01/18 |
Director of Finance/CFO | - | 31/01/20 | |
Chief Operating Officer | - | 31/12/10 |
Members of the board | Title | Age | Since |
---|---|---|---|
Chief Operating Officer | - | 31/12/10 | |
Mark V. Smith
PRN | Corporate Officer/Principal | - | 31/05/14 |
Ross Bjella
CEO | Chief Executive Officer | - | 08/01/18 |
1st Jan change | Capi. | |
---|---|---|
+12.85% | 229B | |
+13.88% | 195B | |
+18.39% | 142B | |
+28.78% | 109B | |
+1.67% | 64.85B | |
+18.24% | 54.33B | |
+7.04% | 52.09B | |
+10.83% | 45.15B | |
+5.94% | 37.39B |